Literature DB >> 31636457

Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.

Shalom Hillel Roth1, Erez Y Levanon1, Eli Eisenberg2,3.   

Abstract

Adenosine-to-inosine (A-to-I) RNA editing by the adenosine deaminase that acts on RNA (ADAR) enzymes is a common RNA modification, preventing false activation of the innate immune system by endogenous double-stranded RNAs. Methods for quantification of ADAR activity are sought after, due to an increasing interest in the role of ADARs in cancer and autoimmune disorders, as well as attempts to harness the ADAR enzymes for RNA engineering. Here, we present the Alu editing index (AEI), a robust and simple-to-use computational tool devised for this purpose. We describe its properties and demonstrate its superiority to current quantification methods of ADAR activity. The AEI is used to map global editing across a large dataset of healthy human samples and identify putative regulators of ADAR, as well as previously unknown factors affecting the observed Alu editing levels. These should be taken into account in future comparative studies of ADAR activity. The AEI tool is available at https://github.com/a2iEditing/RNAEditingIndexer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31636457     DOI: 10.1038/s41592-019-0610-9

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   47.990


  62 in total

Review 1.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1.

Authors:  Jongchan Yeo; Rena A Goodman; Nicole T Schirle; Sheila S David; Peter A Beal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-10       Impact factor: 11.205

3.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.

Authors:  B Sommer; M Köhler; R Sprengel; P H Seeburg
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

Review 4.  A-to-I RNA editing - immune protector and transcriptome diversifier.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Nat Rev Genet       Date:  2018-08       Impact factor: 53.242

5.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.

Authors:  Leilei Chen; Yan Li; Chi Ho Lin; Tim Hon Man Chan; Raymond Kwok Kei Chow; Yangyang Song; Ming Liu; Yun-Fei Yuan; Li Fu; Kar Lok Kong; Lihua Qi; Yan Li; Na Zhang; Amy Hin Yan Tong; Dora Lai-Wan Kwong; Kwan Man; Chung Mau Lo; Si Lok; Daniel G Tenen; Xin-Yuan Guan
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

6.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing.

Authors:  C M Burns; H Chu; S M Rueter; L K Hutchinson; H Canton; E Sanders-Bush; R B Emeson
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

Review 7.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

8.  Dynamic landscape and regulation of RNA editing in mammals.

Authors:  Meng How Tan; Qin Li; Raghuvaran Shanmugam; Robert Piskol; Jennefer Kohler; Amy N Young; Kaiwen Ivy Liu; Rui Zhang; Gokul Ramaswami; Kentaro Ariyoshi; Ankita Gupte; Liam P Keegan; Cyril X George; Avinash Ramu; Ni Huang; Elizabeth A Pollina; Dena S Leeman; Alessandra Rustighi; Y P Sharon Goh; Ajay Chawla; Giannino Del Sal; Gary Peltz; Anne Brunet; Donald F Conrad; Charles E Samuel; Mary A O'Connell; Carl R Walkley; Kazuko Nishikura; Jin Billy Li
Journal:  Nature       Date:  2017-10-11       Impact factor: 49.962

9.  Inosine induces context-dependent recoding and translational stalling.

Authors:  Konstantin Licht; Markus Hartl; Fabian Amman; Dorothea Anrather; Michael P Janisiw; Michael F Jantsch
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

10.  RNA editing of Filamin A pre-mRNA regulates vascular contraction and diastolic blood pressure.

Authors:  Mamta Jain; Tomer D Mann; Maja Stulić; Shailaja P Rao; Andrijana Kirsch; Dieter Pullirsch; Xué Strobl; Claus Rath; Lukas Reissig; Kristin Moreth; Tanja Klein-Rodewald; Raffi Bekeredjian; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Eleonore Pablik; Laura Cimatti; David Martin; Jelena Zinnanti; Wolfgang F Graier; Maria Sibilia; Saša Frank; Erez Y Levanon; Michael F Jantsch
Journal:  EMBO J       Date:  2018-08-07       Impact factor: 11.598

View more
  32 in total

Review 1.  ADARs, RNA editing and more in hematological malignancies.

Authors:  Phaik Ju Teoh; Mun Yee Koh; Wee Joo Chng
Journal:  Leukemia       Date:  2020-11-02       Impact factor: 11.528

2.  Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution.

Authors:  David Dierks; Miguel Angel Garcia-Campos; Anna Uzonyi; Modi Safra; Sarit Edelheit; Alice Rossi; Theodora Sideri; Radhika A Varier; Alexander Brandis; Yonatan Stelzer; Folkert van Werven; Ruth Scherz-Shouval; Schraga Schwartz
Journal:  Nat Methods       Date:  2021-09-03       Impact factor: 28.547

3.  ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis.

Authors:  Ting Zhang; Chaoran Yin; Aleksandr Fedorov; Liangjun Qiao; Hongliang Bao; Nazar Beknazarov; Shiyu Wang; Avishekh Gautam; Riley M Williams; Jeremy Chase Crawford; Suraj Peri; Vasily Studitsky; Amer A Beg; Paul G Thomas; Carl Walkley; Yan Xu; Maria Poptsova; Alan Herbert; Siddharth Balachandran
Journal:  Nature       Date:  2022-05-25       Impact factor: 69.504

4.  Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.

Authors:  Qi Zhang; Bingqiu Xiu; Liyi Zhang; Ming Chen; Weiru Chi; Lun Li; Rong Guo; Jingyan Xue; Benlong Yang; Xiaoyan Huang; Zhi-Ming Shao; Shenglin Huang; Yayun Chi; Jiong Wu
Journal:  J Immunother Cancer       Date:  2022-10       Impact factor: 12.469

5.  Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.

Authors:  Zhong Wu; Jin Zhou; Xiaoyang Zhang; Zhouwei Zhang; Yingtian Xie; Jie Bin Liu; Zandra V Ho; Arpit Panda; Xintao Qiu; Paloma Cejas; Israel Cañadas; Fahire Goknur Akarca; James M McFarland; Ankur K Nagaraja; Louisa B Goss; Nikolas Kesten; Longlong Si; Klothilda Lim; Yanli Liu; Yanxi Zhang; Ji Yeon Baek; Yang Liu; Deepa T Patil; Jonathan P Katz; Josephine Hai; Chunyang Bao; Matthew Stachler; Jun Qi; Jeffrey J Ishizuka; Hiroshi Nakagawa; Anil K Rustgi; Kwok-Kin Wong; Matthew Meyerson; David A Barbie; Myles Brown; Henry Long; Adam J Bass
Journal:  Nat Genet       Date:  2021-05-10       Impact factor: 41.307

6.  Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity.

Authors:  Michal Barak; Hagit T Porath; Gilad Finkelstein; Binyamin A Knisbacher; Ilana Buchumenski; Shalom Hillel Roth; Erez Y Levanon; Eli Eisenberg
Journal:  Genome Biol       Date:  2020-02-07       Impact factor: 13.583

7.  CSI NGS Portal: An Online Platform for Automated NGS Data Analysis and Sharing.

Authors:  Omer An; Kar-Tong Tan; Ying Li; Jia Li; Chan-Shuo Wu; Bin Zhang; Leilei Chen; Henry Yang
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

8.  Spatially regulated editing of genetic information within a neuron.

Authors:  Isabel C Vallecillo-Viejo; Noa Liscovitch-Brauer; Juan F Diaz Quiroz; Maria F Montiel-Gonzalez; Sonya E Nemes; Kavita J Rangan; Simon R Levinson; Eli Eisenberg; Joshua J C Rosenthal
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

9.  Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.

Authors:  Salvatore Di Giorgio; Filippo Martignano; Maria Gabriella Torcia; Giorgio Mattiuz; Silvestro G Conticello
Journal:  Sci Adv       Date:  2020-06-17       Impact factor: 14.957

10.  Quantifying RNA Editing in Deep Transcriptome Datasets.

Authors:  Claudio Lo Giudice; Domenico Alessandro Silvestris; Shalom Hillel Roth; Eli Eisenberg; Graziano Pesole; Angela Gallo; Ernesto Picardi
Journal:  Front Genet       Date:  2020-03-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.